Hematologic Oncology Update
A podcast by Research To Practice
561 Episodio
-
Multiple Myeloma Update 1 2018 | Interview with Paul G Richardson, MD
Pubblicato: 12/01/2018 -
Multiple Myeloma Update 1 2018 | Interview with Shaji K Kumar, MD
Pubblicato: 12/01/2018 -
Acute Leukemias Update 2 2017 | Interview with Wendy Stock, MD
Pubblicato: 09/01/2018 -
Acute Leukemias Update 2 2017 | Interview with Eytan Stein, MD
Pubblicato: 09/01/2018 -
Lymphoma CLL Update 2 2017 | Interview with Jeremy Abramson, MD
Pubblicato: 30/11/2017 -
Lymphoma CLL Update 2 2017 | Interview with Ajay K Gopal, MD
Pubblicato: 30/11/2017 -
Acute Leukemias Update 1 2017 | Interview with Daniel J DeAngelo, MD, PhD
Pubblicato: 27/11/2017 -
Acute Leukemias Update 1 2017 | Interview with Amir T Fathi, MD
Pubblicato: 27/11/2017 -
Tumor Lysis 2017 | Interview with William Wierda, MD, PhD
Pubblicato: 08/11/2017 -
Tumor Lysis 2017 | Interview with Amit Lahoti, MD
Pubblicato: 08/11/2017 -
Hem Investigators 2017 | Interview with Jonathan W Friedberg, MD, MMSc
Pubblicato: 16/10/2017 -
Hem Investigators 2017 | Interview with S Vincent Rajkumar, MD
Pubblicato: 16/10/2017 -
MPNUpdate117 | Interview with Professor Claire N Harrison, MD
Pubblicato: 09/10/2017 -
MPNUpdate117 | Interview with Srdan Verstovsek, MD, PhD
Pubblicato: 06/10/2017 -
Lymphoma CLL Update 1 2017 | Interview with Stephen Maxted Ansell, MD, PhD
Pubblicato: 22/09/2017 -
Lymphoma CLL Update 1 2017 | Interview with Ann S LaCasce, MD, MMSc
Pubblicato: 22/09/2017 -
MDSU1 2017 | Interview with Mikkael A Sekeres, MD, MS
Pubblicato: 03/08/2017 -
MDSU1 2017 | Interview with Steven D Gore, MD
Pubblicato: 02/08/2017 -
MMTT1 2017 | Current Clinical Algorithms and Recent Therapeutic Advances in the Management of Multiple Myeloma and Related Blood Disorders
Pubblicato: 16/06/2017 -
MMTT1 2017 | CME Information and Program PDF
Pubblicato: 16/06/2017
Featuring one-on-one interviews conducted by Dr Neil Love, this series provides medical oncologists with access to an array of important perspectives and information on relevant advances in the treatment of hematologic cancer to facilitate optimal patient care.
